SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

The Company is in ongoing dialogue with the FDA regarding the submission of a Biologics License Appl

CADL

Related stories